Democrats Unlikely To Use CRA To Kill Trump Drug Pricing Rules

By John Wilkerson / March 31, 2021 at 4:43 PM
The deadline for using the Congressional Review Act is fast approaching with no sign that Democrats plan to use that law to kill drug pricing rules released at the end of the Trump administration. However, congressional Democrats might not need to repeal those regulations because many are tied up in court, and Democrats may want the administration to delay, but not get rid of, a drug rebate ban rule that they could nix later to help pay for their upcoming...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.